ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
13
views
0
references
Top references
cited by
90
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,890
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Molecular basis of restenosis and drug-eluting stents.
Author(s):
D. Simon
,
M. Costa
Publication date:
2005-05-03
Journal:
Circulation
Keywords:
Animals
,
Antineoplastic Agents
,
therapeutic use
,
Cell Proliferation
,
Coronary Restenosis
,
etiology
,
prevention & control
,
Endothelium, Vascular
,
pathology
,
Graft Occlusion, Vascular
,
Humans
,
Immunosuppressive Agents
,
Inflammation
,
complications
,
Pharmaceutical Preparations
,
administration & dosage
,
Stents
,
adverse effects
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via free pdf)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Drug_transporters
Author and article information
Journal
PubMed ID::
15867193
DOI::
10.1161/01.CIR.0000163587.36485.A7
ScienceOpen disciplines:
Chemistry
Keywords:
Animals
,
Antineoplastic Agents
,
therapeutic use
,
Cell Proliferation
,
Coronary Restenosis
,
etiology
,
prevention & control
,
Endothelium, Vascular
,
pathology
,
Graft Occlusion, Vascular
,
Humans
,
Immunosuppressive Agents
,
Inflammation
,
complications
,
Pharmaceutical Preparations
,
administration & dosage
,
Stents
,
adverse effects
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Animals
,
Antineoplastic Agents
,
therapeutic use
,
Cell Proliferation
,
Coronary Restenosis
,
etiology
,
prevention & control
,
Endothelium, Vascular
,
pathology
,
Graft Occlusion, Vascular
,
Humans
,
Immunosuppressive Agents
,
Inflammation
,
complications
,
Pharmaceutical Preparations
,
administration & dosage
,
Stents
,
adverse effects
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,890
Chemokine expression in coronary circulation after coronary angioplasty as a prognostic factor for restenosis.
Authors:
Yukihiro Hojo
,
Uichi Ikeda
,
Taka-aki Katsuki
…
Transluminal Extraction Atherectomy for Restenosis Following Palmaz-Schatz Stent Implantation
Authors:
Kazuhiro Hara
,
Yuji Ikari
,
Tsutomu Tamura
…
Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis.
Authors:
Kerry K Karukstis
,
Jarrod Scott
,
P Winter
…
See all similar
Cited by
89
Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014
Authors:
Robert A Byrne
,
Michael Joner
,
Adnan Kastrati
Mesenchymal stem cells loaded with paclitaxel-poly(lactic- co -glycolic acid) nanoparticles for glioma-targeting therapy
Authors:
Xiaoling Wang
,
Jianqing Gao
,
Xumei Ouyang
…
Gelatin nanoparticles: a potential candidate for medical applications
Authors:
Rehana Yasmin
,
Mohsin Shah
,
Saeed Ahmad Khan
…
See all cited by